NO138566C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,1,3-benzotiadiazol-derivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,1,3-benzotiadiazol-derivater

Info

Publication number
NO138566C
NO138566C NO1801/73A NO180173A NO138566C NO 138566 C NO138566 C NO 138566C NO 1801/73 A NO1801/73 A NO 1801/73A NO 180173 A NO180173 A NO 180173A NO 138566 C NO138566 C NO 138566C
Authority
NO
Norway
Prior art keywords
benzotiadiazole
derivatives
preparation
therapeutic active
analogical procedure
Prior art date
Application number
NO1801/73A
Other languages
English (en)
Norwegian (no)
Other versions
NO138566B (no
Inventor
Peter Neumann
Original Assignee
Wander Ag Dr A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wander Ag Dr A filed Critical Wander Ag Dr A
Publication of NO138566B publication Critical patent/NO138566B/no
Publication of NO138566C publication Critical patent/NO138566C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
NO1801/73A 1972-05-09 1973-05-02 Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,1,3-benzotiadiazol-derivater NO138566C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH686572A CH570401A5 (xx) 1972-05-09 1972-05-09

Publications (2)

Publication Number Publication Date
NO138566B NO138566B (no) 1978-06-19
NO138566C true NO138566C (no) 1978-09-27

Family

ID=4316243

Family Applications (1)

Application Number Title Priority Date Filing Date
NO1801/73A NO138566C (no) 1972-05-09 1973-05-02 Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,1,3-benzotiadiazol-derivater

Country Status (26)

Country Link
US (1) US3843668A (xx)
JP (3) JPS5533718B2 (xx)
AT (1) AT336006B (xx)
BE (1) BE799332A (xx)
CH (1) CH570401A5 (xx)
CS (2) CS202052B2 (xx)
CY (1) CY989A (xx)
DD (1) DD106180A5 (xx)
DE (1) DE2322880C2 (xx)
DK (1) DK135454B (xx)
ES (3) ES414470A1 (xx)
FI (1) FI60010C (xx)
FR (1) FR2183930B1 (xx)
GB (2) GB1429926A (xx)
HK (1) HK11179A (xx)
HU (1) HU166329B (xx)
IE (1) IE38012B1 (xx)
IL (2) IL49205A (xx)
MY (1) MY7900117A (xx)
NL (1) NL161445C (xx)
NO (1) NO138566C (xx)
PL (1) PL89214B1 (xx)
SE (1) SE386445B (xx)
SU (1) SU493966A3 (xx)
YU (4) YU36174B (xx)
ZA (1) ZA733143B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5930899B2 (ja) * 1973-02-01 1984-07-30 隆弘 上野 内燃機関の制動方法及びその装置
GB1559811A (en) * 1975-07-28 1980-01-30 Sandoz Ltd Pharmaceutically active benzothiadiazole derivatives
CH613966A5 (en) * 1975-08-22 1979-10-31 Sandoz Ag Process for the preparation of novel 5-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazoles
US4217356A (en) * 1975-08-22 1980-08-12 Sandoz Ltd. 2-Imidazolinylamino-2,1,3-benzothiadiazoles
CH632268A5 (de) * 1977-01-14 1982-09-30 Sandoz Ag Verfahren zur herstellung von neuen heterocyclylaminoderivaten.
FR2499991A1 (fr) * 1981-02-19 1982-08-20 Sandoz Sa Nouveaux 2,1,3-benzothiadiazoles et 2,1,3-benzoxadiazoles, leur preparation et leur application comme medicaments
FR2502951B1 (fr) * 1981-04-06 1985-12-06 Sandoz Sa Compositions pharmaceutiques topiques sous forme d'une micro-emulsion
JPS5826094U (ja) * 1981-08-13 1983-02-19 ヤマハ株式会社 電子楽器の制御装置
JPS61268828A (ja) * 1985-05-22 1986-11-28 Kubota Ltd 圧縮空気取出装置付き容積形内燃機関
JPH0622121Y2 (ja) * 1988-01-18 1994-06-08 川崎重工業株式会社 空気圧縮機兼用多気筒エンジン
JP2668816B2 (ja) * 1993-09-09 1997-10-27 株式会社パーマケム・アジア ベンゾチアジアゾール誘導体の製法
US6455557B1 (en) 2001-11-28 2002-09-24 Elan Pharmaceuticals, Inc. Method of reducing somnolence in patients treated with tizanidine
US20040220240A1 (en) * 2001-11-28 2004-11-04 Pellegrini Cara A. Method of increasing the extent of absorption of tizanidine
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
GB0224198D0 (en) * 2002-10-17 2002-11-27 Novartis Ag Organic compounds
EP2218442A1 (en) 2005-11-09 2010-08-18 CombinatoRx, Inc. Methods, compositions, and kits for the treatment of ophthalmic disorders
WO2008008394A1 (en) * 2006-07-12 2008-01-17 Transform Pharmaceuticals, Inc. Tizanidine succinate salt forms and methods of making and using the same
US8524749B2 (en) * 2007-02-09 2013-09-03 Alza Corporation Controlled release compositions of tizanidine
CZ301889B6 (cs) 2008-12-18 2010-07-21 Farmak, A. S. Zpusob prípravy tizanidinu hydrochloridu
ES2637387T3 (es) 2011-10-24 2017-10-13 Braeburn Pharmaceuticals, Inc. Composiciones de tizanidina implantables y procedimientos de tratamiento asociados
CN106946874A (zh) * 2017-04-07 2017-07-14 四川智强医药科技开发有限公司 替扎尼定的脱色方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1211341A (fr) * 1955-12-19 1960-03-15 A Wander Dr Procédé pour la préparation de 2-amino-imidazolines
BE754832A (fr) * 1969-08-14 1971-02-15 Beecham Group Ltd Iminazolines

Also Published As

Publication number Publication date
IE38013L (en) 1973-11-09
GB1429683A (en) 1976-03-24
DK135454C (xx) 1977-10-17
AT336006B (de) 1977-04-12
FI60010B (fi) 1981-07-31
FI60010C (fi) 1981-11-10
CY989A (en) 1979-08-02
JPS562071B2 (xx) 1981-01-17
YU119673A (en) 1981-06-30
NL7306228A (xx) 1973-11-13
DE2322880C2 (de) 1982-09-23
FR2183930B1 (xx) 1976-03-05
ES440599A1 (es) 1977-05-16
MY7900117A (en) 1979-12-31
NL161445C (nl) 1980-02-15
GB1429926A (en) 1976-03-31
HK11179A (en) 1979-03-16
CH570401A5 (xx) 1975-12-15
DD106180A5 (xx) 1974-06-05
YU36025B (en) 1981-11-13
DE2322880A1 (de) 1973-11-22
CS208788B2 (en) 1981-09-15
DK135454B (da) 1977-05-02
NO138566B (no) 1978-06-19
IL42231A0 (en) 1973-07-30
ES414470A1 (es) 1976-05-01
YU36174B (en) 1982-02-25
PL89214B1 (xx) 1976-11-30
JPS4954370A (xx) 1974-05-27
IL42231A (en) 1977-06-30
YU36024B (en) 1981-11-13
CS202052B2 (en) 1980-12-31
JPS5533718B2 (xx) 1980-09-02
IL49205A (en) 1977-05-31
YU36026B (en) 1981-11-13
IL49205A0 (en) 1976-05-31
ES440598A1 (es) 1977-05-16
YU50679A (en) 1981-04-30
IE38012B1 (en) 1977-12-07
NL161445B (nl) 1979-09-17
ZA733143B (en) 1975-01-29
US3843668A (en) 1974-10-22
YU50479A (en) 1981-04-30
JPS5350168A (en) 1978-05-08
SE386445B (sv) 1976-08-09
JPS5543081A (en) 1980-03-26
FR2183930A1 (xx) 1973-12-21
YU50579A (en) 1981-04-30
JPS5442983B2 (xx) 1979-12-17
BE799332A (fr) 1973-11-09
AU5540873A (en) 1974-11-14
ATA403273A (de) 1976-08-15
SU493966A3 (ru) 1975-11-28
HU166329B (xx) 1975-02-28

Similar Documents

Publication Publication Date Title
NO138335C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive alkanolaminer
NO140381C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner
NO138566C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,1,3-benzotiadiazol-derivater
SE390819B (sv) Analogiforfarande for framstellning av piperazinyl-propyl-1,2,4-triazolinderivat
NO136094C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive d-1-(4-amino-fenyl)-2-alkylamino-etanol-derivater.
NO143575C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive prostansyre-derivater
NO145056C (no) (s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater
NO140058C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater
NO140977C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-amino-1,4-dihydropyridiner
NO139685C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolin-derivater
NO138999C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner
NO140597C (no) Analogifremgangsmaate ved fremstillingen av terapeutisk aktive 8-azapurin-6-on-derivater
NO137899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n (1h-tetrazol-5-yl)-kinaldamider
NO137966C (no) Analogifremgangsmaate til fremstilling av antibakterielt virksomme 5-oksopyrido-(2,3-d)-pyrimidinderivater
NO141850C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater.
NO137858C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner
NO139088C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2beta,16beta-diamino-5alfa-androstaner
NO137728C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater
NO139050C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nororipavin- og tebainderivater
SE388611B (sv) Analogiforfarande for framstellning av 1,4-bensodiazeponderivat
SE403612B (sv) Analogiforfarande for framstellning av antibakteriellt aktiva hexametylen-bis-biguanider
NO137727C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyl-3-hydroksy-3-metyltriazener
SE403112B (sv) Analogiforfarande for framstellning av skopolaminderivat
NO137998C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tebain- og oripavin-derivater
NO137695C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-tienylmetyl-heterocykliske forbindelser